Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) represent a rare and heterogenous tumor entity. Importantly, the highly proliferative subgroup of neuroendocrine carcinoma (GEP-NEC) is characterized by high resistance to conventional chemotherapy. Consequently, there is an urgent need to id...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Dizdar, Levent, Oesterwind, Kira A., Riemer, Jasmin C., Werner, Thomas A., Mersch, Sabrina, Möhlendick, Birte, Schütte, Sina C., Verde, Pablo E., Raba, Katharina, Topp, Stefan A., Stoecklein, Nikolas H., Esposito, Irene, Knoefel, Wolfram T., Krieg, Andreas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352407/
https://ncbi.nlm.nih.gov/pubmed/28039474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14207
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak